The weekly litigation news digest is live. Subscribe now

Vectors For Transgene Expression - EP3060668

The patent EP3060668 was granted to Adaptimmune on Oct 19, 2022. The application was originally filed on Oct 24, 2014 under application number EP14792441A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3060668

ADAPTIMMUNE
Application Number
EP14792441A
Filing Date
Oct 24, 2014
Status
Patent Maintained As Amended
Sep 16, 2022
Publication Date
Oct 19, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BISCHOF & PARTNER RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBMar 18, 2020MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2012170911
OPPOSITIONUS6284469
OPPOSITIONWO2012170911

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents